Zeus has named Suresh Sainath as Chief Technology Officer where he will head the Research & Development division, leveraging the advanced capabilities of company components and contract manufacturing to create an industry-leading portfolio of new products and services.
 
Sainath has led and co-founded several successful Medtech companies, including CathX Medical, which Zeus acquired in June 2021. Under his leadership, Zeus’ catheter solutions division saw notable growth, doubling revenue, workforce, capabilities, and global footprint.
 
“We are making significant investments in research and development, and it’s exciting to have one of the industry’s top innovators lead us into the future,” said Zeus CEO, Paddy O’Brien. “Suresh has a wealth of experience and expertise across med device design, emerging technologies, and developing next-gen catheter solutions. I’m confident his leadership over R&D will further strengthen our commitment to innovation and excellence and reinforce our value as a strategic supplier to customers.”
 
Suresh Sainath commented: “Innovation has been at the core of Zeus since day one. I’m honored to work with a highly talented team of researchers, material scientists, and engineers, and look forward to collaborating with customers to help solve their challenges. With a dedicated focus on developing end-to-end catheter solutions using the most advanced technologies and the highest quality components, we can help streamline our customers’ supply chain by increasing speed to market, lowering costs, and reducing risks throughout a product’s lifecycle.”